This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Aug 11;387(6):573.

doi: 10.1056/NEJMc2208623.

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

Donjetë Simnica¹, Sebastian Kobold¹

Affiliations

PMID: 35947720
DOI: 10.1056/NEJMc2208623

Comment

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

Donjetë Simnica et al. N Engl J Med. 2022.

. 2022 Aug 11;387(6):573.

doi: 10.1056/NEJMc2208623.

Authors

Donjetë Simnica¹, Sebastian Kobold¹

Affiliation

¹ LMU Klinikum, Munich, Germany sebastian.kobold@med.uni-muenchen.de.

PMID: 35947720
DOI: 10.1056/NEJMc2208623

No abstract available

PubMed Disclaimer

Comment in

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply.
Tran E, Urba WJ, Leidner R. Tran E, et al. N Engl J Med. 2022 Aug 11;387(6):574. doi: 10.1056/NEJMc2208623. N Engl J Med. 2022. PMID: 35947721 No abstract available.

Comment on

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer.
Leidner R, Sanjuan Silva N, Huang H, Sprott D, Zheng C, Shih YP, Leung A, Payne R, Sutcliffe K, Cramer J, Rosenberg SA, Fox BA, Urba WJ, Tran E. Leidner R, et al. N Engl J Med. 2022 Jun 2;386(22):2112-2119. doi: 10.1056/NEJMoa2119662. N Engl J Med. 2022. PMID: 35648703 Free PMC article.

Similar articles

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. Reply.
Tran E, Urba WJ, Leidner R. Tran E, et al. N Engl J Med. 2022 Aug 11;387(6):574. doi: 10.1056/NEJMc2208623. N Engl J Med. 2022. PMID: 35947721 No abstract available.
T-cell Receptor Gene Therapy Clinically Targeting a TP53 Public Neoantigen.
Klebanoff CA. Klebanoff CA. Cancer Immunol Res. 2022 Aug 3;10(8):919. doi: 10.1158/2326-6066.CIR-22-0386. Cancer Immunol Res. 2022. PMID: 35767244
Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
Linette GP, Becker-Hapak M, Skidmore ZL, Baroja ML, Xu C, Hundal J, Spencer DH, Fu W, Cummins C, Robnett M, Kaabinejadian S, Hildebrand WH, Magrini V, Demeter R, Krupnick AS, Griffith OL, Griffith M, Mardis ER, Carreno BM. Linette GP, et al. Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23662-23670. doi: 10.1073/pnas.1906026116. Epub 2019 Nov 4. Proc Natl Acad Sci U S A. 2019. PMID: 31685621 Free PMC article.
Killing the "BAD": Challenges for immunotherapy in pancreatic cancer.
Li TJ, Wang WQ, Yu XJ, Liu L. Li TJ, et al. Biochim Biophys Acta Rev Cancer. 2020 Aug;1874(1):188384. doi: 10.1016/j.bbcan.2020.188384. Epub 2020 Jun 9. Biochim Biophys Acta Rev Cancer. 2020. PMID: 32531324 Review.
MHC class II restricted neoantigen: A promising target in tumor immunotherapy.
Sun Z, Chen F, Meng F, Wei J, Liu B. Sun Z, et al. Cancer Lett. 2017 Apr 28;392:17-25. doi: 10.1016/j.canlet.2016.12.039. Epub 2017 Jan 16. Cancer Lett. 2017. PMID: 28104443 Review.

See all similar articles

Cited by

CircHLA-C: A significantly upregulated circRNA co-existing in oral leukoplakia and oral lichen planus.
Yang J, Song Y, Xu S, Ge S, Haiwen Z. Yang J, et al. Organogenesis. 2023 Dec 31;19(1):2234504. doi: 10.1080/15476278.2023.2234504. Organogenesis. 2023. PMID: 37531467 Free PMC article.
Improving outcomes of patients with pancreatic cancer.
Dreyer SB, Beer P, Hingorani SR, Biankin AV. Dreyer SB, et al. Nat Rev Clin Oncol. 2025 Jun;22(6):439-456. doi: 10.1038/s41571-025-01019-9. Epub 2025 May 6. Nat Rev Clin Oncol. 2025. PMID: 40329051 Review.
Characterizing and forecasting neoantigens-resulting from MUC mutations in COAD.
Chen M, Zhang X, Ming Z, Lingyu, Feng X, Han Z, An HX. Chen M, et al. J Transl Med. 2024 Mar 27;22(1):315. doi: 10.1186/s12967-024-05103-z. J Transl Med. 2024. PMID: 38539235 Free PMC article.
Immune status and combined immunotherapy progression in Kirsten rat sarcoma viral oncogene homolog (KRAS)-mutant tumors.
He D, Bai R, Chen N, Cui J. He D, et al. Chin J Cancer Res. 2024 Aug 30;36(4):421-441. doi: 10.21147/j.issn.1000-9604.2024.04.06. Chin J Cancer Res. 2024. PMID: 39246706 Free PMC article.
Immunotherapy in the Fight Against Bone Metastases: A Review of Recent Developments and Challenges.
Peng Z, Huang W, Xiao Z, Wang J, Zhu Y, Zhang F, Lan D, He F. Peng Z, et al. Curr Treat Options Oncol. 2024 Nov;25(11):1374-1389. doi: 10.1007/s11864-024-01256-7. Epub 2024 Oct 22. Curr Treat Options Oncol. 2024. PMID: 39436492 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information